<DOC>
	<DOCNO>NCT00064649</DOCNO>
	<brief_summary>The primary objective randomize clinical trial determine efficacy safety three treatment benign prostatic hyperplasia ( BPH ) : transurethral needle ablation ( TUNA ) , transurethral microwave therapy ( TUMT ) , medical therapy alfuzosin finasteride .</brief_summary>
	<brief_title>Minimally Invasive Surgical Therapy BPH</brief_title>
	<detailed_description />
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Finasteride</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<criteria>Inclusion Patient sign informed consent prior performance study procedure discontinuation exclusionary medication . Male least 50 year age . AUA symptom severity score &gt; = 10 . Voided volume &gt; = 100 ml . Postvoid residual &lt; 350 ml . Prostatic length 3050 mm cystoscopy ( bladder neck verumontanum ) 3560 mm TRUS ( bladder neck apex ) . Prostate volume 25100 cc TRUS . Prostate transverse diameter 3480 mm . Patient able complete study protocol opinion investigator . Exclusion Any prior surgical intervention BPH . Enrolled another treatment trial disease within past 30 day . Previously fail respond combination therapy alpha blocker 5alpha reductase inhibitor . Previous hypersensitivity , idiosyncrasy , clinically suspect drug reaction alfuzosin finasteride . On alphablocker within past month . On 5alpha reductase inhibitor within past 4 month . On phenylephrine , pseudoephedrine , imipramine , anticholinergic cholinergic medication within past 2 week . On estrogen , androgen , drug produce androgen suppression , anabolic steroid within past 4 month . Bleeding disorder take anticoagulation medication unless patient able antiplatelet medication least 10 day prior MIST treatment . Clinically significant renal hepatic impairment determine abnormal creatinine AST level ( i.e. , creatinine &gt; 2.0 mg/dL AST &gt; 1.5 time upper limit institutional norm ) . Serum prostate specific antigen level &gt; 10 ng/ml . Active urinary tract infection determine positive culture , bacterial prostatitis within past year document positive culture , two document urinary tract infection type past year ( UTI define &gt; 100,000 colony per ml urine midstream clean catch catheterize specimen ) . Biopsy prostate within past 6 week . Daily use pad device incontinence require International Continence Society male incontinence symptom score &gt; = 13 . Episode unstable angina pectoris , myocardial infarction , transient ischemic attack , cerebrovascular accident ( stroke ) within past 6 month , peripheral arterial disease intermittent claudication Leriches syndrome . Orthostatic hypotension define drop &gt; 20 mm Hg supine stand SPB drop &gt; 10 mm Hg supine stand DBP , either stand BP reading , development symptom postural hypotension ( e.g. , dizzy lightheaded ) . Penile prosthesis . Artificial urinary sphincter implant , metallic nonmetallic , within 1.5 inch prostatic urethra . History current evidence carcinoma prostate bladder , pelvic radiation surgery , urethral stricture require dilation pas flexible cystoscope . Nonsymmetric median prostatic lobe enlargement prominent obstruct `` ball valve '' prostatic lobe determine cystoscopy . Known primary neurologic condition multiple sclerosis Parkinson 's disease , component implantable neurostimulation system , neurological disease know affect bladder function . Cancer consider cure , except basal cell squamous cell carcinoma skin ( cure define evidence cancer within past 5 year ) . Defibrillator pacemaker deactivate MIST . Neurogenic decompensated atonic bladder opinion investigator . Patient interest future fertility . Previous rectal surgery hemorrhoidectomy . Any serious medical condition likely impede successful completion study .</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>prostate</keyword>
	<keyword>benign disease</keyword>
	<keyword>TUNA</keyword>
	<keyword>TUMT</keyword>
	<keyword>medical therapy</keyword>
</DOC>